Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ingredion | INGR | Apr 26, 2024 | 113.29 | -1.04 |
Inhibikase Therapeutics | IKT | Apr 26, 2024 | 1.71 | -10.00 |
Inhibrx | INBX | Apr 26, 2024 | 34.06 | -0.09 |
InMed | INM | Apr 26, 2024 | 0.23 | -8.73 |
InMode | INMD | Apr 26, 2024 | 17.14 | +0.71 |
INmune Bio | INMB | Apr 26, 2024 | 11.29 | +4.15 |
Innate Pharma ADR | IPHA | Apr 26, 2024 | 2.46 | +2.50 |
Inno Holdings | INHD | Apr 26, 2024 | 0.63 | +0.60 |
Innodata | INOD | Apr 26, 2024 | 5.92 | +4.04 |
Innospec | IOSP | Apr 26, 2024 | 121.12 | +0.85 |
InnovAge | INNV | Apr 26, 2024 | 3.91 | +2.89 |
Innovate | VATE | Apr 26, 2024 | 0.54 | -3.89 |
Innovative Eyewear | LUCY | Apr 26, 2024 | 0.24 | +1.20 |
Innovative Industrial Properties | IIPR | Apr 26, 2024 | 97.71 | -0.17 |
Innovative Industrial Properties A Pref | IIPR-A | Apr 26, 2024 | 26.79 | +0.70 |
Innovative Solutions and Support | ISSC | Apr 26, 2024 | 6.46 | +0.78 |
Innovid | CTV | Apr 26, 2024 | 2.34 | +2.63 |
Innoviva | INVA | Apr 26, 2024 | 15.26 | +1.80 |
Innoviz Technologies | INVZ | Apr 26, 2024 | 1.18 | +15.69 |
InnSuites Hospitality | IHT | Apr 26, 2024 | 1.43 | +1.11 |
Inogen | INGN | Apr 26, 2024 | 6.78 | +4.63 |
Inotiv | NOTV | Apr 26, 2024 | 4.05 | -5.59 |
Inovio Pharmaceuticals | INO | Apr 26, 2024 | 10.57 | +4.40 |
Inozyme Pharma | INZY | Apr 26, 2024 | 4.44 | +2.54 |
Inpixon | XTIA | Apr 26, 2024 | 2.50 | 0.00 |
InPoint Commercial Real Estate Pref A | ICR-A | Apr 26, 2024 | 19.50 | 0.00 |
Inseego | INSG | Apr 26, 2024 | 3.85 | +9.07 |
Insight Enterprises | NSIT | Apr 26, 2024 | 182.75 | +0.10 |
Insight Select Income Fund | INSI | Apr 26, 2024 | 16.14 | -0.20 |
Insmed | INSM | Apr 26, 2024 | 24.80 | -0.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.